The cost of medicine is always controversial, particularly in an election year. We’ve already seen the Government scrap prescription fees to make them more accessible – but what sort of costs really go in to making and licensing medicine, and how does being publicly listed impact a drugs company?  

For this month's Business Spotlight, Madison is joined by AFT Pharmaceuticals founder and CEO Hartley Atkinson to discuss his business and how these changes could impact the industry - plus, the story behind AFT's first dividend payment and why he thinks some parts of big pharma are the enemy. 

See omnystudio.com/listener for privacy information.